94 related articles for article (PubMed ID: 9258352)
1. Anti-Helicobacter pylori agents. 1. 2-(Alkylguanidino)-4-furylthiazoles and related compounds.
Katsura Y; Tomishi T; Inoue Y; Sakane K; Matsumoto Y; Ishikawa H; Takasugi H
J Med Chem; 1997 Aug; 40(16):2462-5. PubMed ID: 9258352
[TBL] [Abstract][Full Text] [Related]
2. Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles.
Katsura Y; Nishino S; Ohno M; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 1999 Jul; 42(15):2920-6. PubMed ID: 10425101
[TBL] [Abstract][Full Text] [Related]
3. Anti-Helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles.
Katsura Y; Nishino S; Tomishi T; Sakane K; Matsumoto Y; Ishikawa H; Takasugi H
Bioorg Med Chem Lett; 1998 Jun; 8(11):1307-12. PubMed ID: 9871756
[TBL] [Abstract][Full Text] [Related]
4. Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives.
Katsura Y; Tomishi T; Inoue Y; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 2000 Aug; 43(17):3315-21. PubMed ID: 10966750
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of 2-[[(2-pyridyl)methyl]thio]-1H- benzimidazoles as anti Helicobacter pylori agents in vitro and evaluation of their in vivo efficacy.
Kühler TC; Swanson M; Shcherbuchin V; Larsson H; Mellgârd B; Sjöström JE
J Med Chem; 1998 May; 41(11):1777-88. PubMed ID: 9599229
[TBL] [Abstract][Full Text] [Related]
6. Anti-Helicobacter pylori agents. 5. 2-(Substituted guanidino)-4-arylthiazoles and aryloxazole analogues.
Katsura Y; Nishino S; Inoue Y; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 2002 Jan; 45(1):143-50. PubMed ID: 11754586
[TBL] [Abstract][Full Text] [Related]
7. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
8. Anti-Helicobacter pylori agents endowed with H2-antagonist properties.
Sorba G; Bertinaria M; Di Stilo A; Gasco A; Scaltrito MM; Brenciaglia MI; Dubini F
Bioorg Med Chem Lett; 2001 Feb; 11(3):403-6. PubMed ID: 11212121
[TBL] [Abstract][Full Text] [Related]
9. Histamine-2 receptor expression in gastric mucosa before and after Helicobacter pylori cure.
Osawa H; Kita H; Ohnishi H; Mutoh H; Ishino Y; Satoh K; Sugano K
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():92-8. PubMed ID: 15943854
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain.
Foroumadi A; Rineh A; Emami S; Siavoshi F; Massarrat S; Safari F; Rajabalian S; Falahati M; Lotfali E; Shafiee A
Bioorg Med Chem Lett; 2008 Jun; 18(11):3315-20. PubMed ID: 18442909
[TBL] [Abstract][Full Text] [Related]
11. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.
Konturek SJ; Konturek PC; Brzozowski T; Konturek JW; Pawlik WW
J Physiol Pharmacol; 2005 Dec; 56(4):507-30. PubMed ID: 16391411
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives.
Chimenti F; Bizzarri B; Manna F; Bolasco A; Secci D; Chimenti P; Granese A; Rivanera D; Lilli D; Scaltrito MM; Brenciaglia MI
Bioorg Med Chem Lett; 2005 Feb; 15(3):603-7. PubMed ID: 15664821
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and assessment of formamidines as new histamine H2-receptor antagonists.
Anglada L; Raga M; Márquez M; Sacristán A; Castelló JM; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):431-4. PubMed ID: 9205738
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo anti-Helicobacter pylori activity of Calophyllum brasiliense Camb.
Souza Mdo C; Beserra AM; Martins DC; Real VV; Santos RA; Rao VS; Silva RM; Martins DT
J Ethnopharmacol; 2009 Jun; 123(3):452-8. PubMed ID: 19501278
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori.
Park BS; Lee HK; Lee SE; Piao XL; Takeoka GR; Wong RY; Ahn YJ; Kim JH
J Ethnopharmacol; 2006 Apr; 105(1-2):255-62. PubMed ID: 16359837
[TBL] [Abstract][Full Text] [Related]
16. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori.
Shirin H; Moss SF; Kancherla S; Kancherla K; Holt PR; Weinstein IB; Sordillo EM
J Gastroenterol Hepatol; 2006 Sep; 21(9):1388-93. PubMed ID: 16911681
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives.
Nam G; Kang TW; Shin JH; Choi KI
Bioorg Med Chem Lett; 2006 Feb; 16(3):569-72. PubMed ID: 16275089
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
19. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
[TBL] [Abstract][Full Text] [Related]
20. Metronidazole-flavonoid derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8 production by AGS cells.
Li HQ; Xu C; Li HS; Xiao ZP; Shi L; Zhu HL
ChemMedChem; 2007 Sep; 2(9):1361-9. PubMed ID: 17628869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
